Back to Search
PHILIP LEESE, M.D.
M.D.
Internal Medicine Physician
NPI: 1205955374Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Community-based hepatitis B screening programs in the United States in 2008.
PMID 19674286·J Viral Hepat·2010
8-other
Population PK-PD model for Fc-osteoprotegerin in healthy postmenopausal women.
PMID 18633695·J Pharmacokinet Pharmacodyn·2008
8-other
Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist.
PMID 17713157·Antivir Ther·2007
3-trial
Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.
PMID 17654304·Platelets·2007
3-trial
The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rate.
PMID 17577103·J Cardiovasc Pharmacol·2007
4-observational
Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria.
PMID 17415408·PLoS Clin Trials·2007
8-other
QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.
PMID 17414226·J Cardiovasc Pharmacol·2007
4-observational
Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers.
PMID 16765144·Clin Pharmacol Ther·2006
2-rct
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004.
PMID 16432953·J Bone Miner Res·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6700 W 115TH ST
OVERLAND PARK, KS 66211 - Phone
- (913) 708-7555
Quick Facts
- NPI
- 1205955374
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile